Come up with a name for your new list and we'll add to it:
NeuroQuest raised a round of funding on , . Investors include
The Trendlines Group.
NeuroQuest is a developer of blood-based immune biomarkers. The company's technology has shown that key cellular immunological components in the blood are needed for normal brain function and that the…